Adam Ismail

Adam Ismail has a diverse work experience. Adam currently serves as the Chief Strategy Officer at KD Pharma Group since 2018. Adam is also a Board Member at both the Global Organization for EPA and DHA Omega-3s since 2007 and Acumen Health Holdings since 2018. Prior to their current roles, Adam was the Executive Director at the Global Organization for EPA and DHA Omega-3s from 2007 to 2018. Adam has also worked as a Columnist at Nutraceuticals World Magazine from 1999 to 2012 and as a Manager, Business Development at Cargill from 2004 to 2007. Additionally, they have worked as a Senior Consultant at both Health Strategy Consulting and Health Business Partners from 1999 to 2002.

Adam Ismail earned their Bachelor of Science in Business Administration (BSBA) with a focus on Finance and Organizational Behavior from the Questrom School of Business at Boston University from 1995 to 1999. Later, they pursued their Master of Business Administration (MBA) with a specialization in Finance and Management from the IESE Business School between 2002 and 2004.